Frontiers in Oncology | Hematologic Malignancies

Original Research

Accepted on 12 Sep 2025

Ibrutinib Combined with Rituximab and High-Dose Methotrexate (IRM) in Newly Diagnosed Primary CNS Diffuse Large B-Cell Lymphoma: A Pilot Study with Long-Term Follow-Up

in Hematologic Malignancies

Yixian Guo
Yongzhi Shan
Yueshan Piao
Xiaoli Chang
Dongmei Zou
Qiang Ma
Yukui Wei
Geng Xu
Yaming Wang
Dandan Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1669385

277 views

Perspective

Published on 12 Sep 2025

Enhancing diagnostics through flow cytometry: overcoming barriers in low resource settings

in Hematologic Malignancies

Jeanine Alfaro
Patricia Valverde
Paola Salguero
Xiomara Arevalo
Pamela Ortega
Luisa Sanchez
Federico Antillon-Klussmann
Randall T. Hayden
Alicia Rodriguez
Monika L. Metzger

Frontiers in Oncology

doi 10.3389/fonc.2025.1604295

316 views

Original Research

Published on 10 Sep 2025

Development of a novel prognostic model for mantle cell lymphoma based on quantitative detection of CD3 by quantitative dot blot

in Hematologic Malignancies

Ning Zhu
Yunjun Wang
Jiajia Hu
Xiaoyan Lin
Cuijuan Zhang
Fangrong Tang
Guohua Yu

Frontiers in Oncology

doi 10.3389/fonc.2025.1595572

509 views

Original Research

Published on 10 Sep 2025

Transcriptome-based immune subtypes reveal the heterogeneity of tumor microenvironment in pediatric B-cell acute lymphocytic leukemia

in Hematologic Malignancies

Hongbin Meng
Xiaoxia Li
Wenyi Hou
Jinqiao Li
Yueyue Fu

Frontiers in Oncology

doi 10.3389/fonc.2025.1643160

454 views

Original Research

Published on 10 Sep 2025

A retrospective analysis of inotuzumab ozogamicin usage in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia

in Hematologic Malignancies

Narendra Agrawal
Pavan K. Boyella
Rahul Bhargava
Chandran K. Nair
Arijit Nag

Frontiers in Oncology

doi 10.3389/fonc.2025.1601782

539 views

Brief Research Report

Accepted on 09 Sep 2025

Current quality of life (QOL) questionnaires are not relevant for assessing QOL issues in multiply myeloma patients in the era of modern therapies: Results from a survey with myeloma patients and myeloma healthcare professionals

in Hematologic Malignancies

Catherine Shin Yee Lecat
Sotirios Bristogiannis
Dipal Mehta
Yadanar Lwin
Joanne Land
Orla Mccourt
Emma Dowling
Nuno Correia
Neil K Rabin
Ke Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1656912

236 views

Original Research

Published on 09 Sep 2025

Risk of hematological malignancies and anticipation in the families of patients with non-Hodgkin and Hodgkin lymphoma

in Hematologic Malignancies

Saad Akhtar
Ali Hassan Mushtaq
Huda Syed
Tusneem Ahmed M. Elhassan
Meshari Jamaan Alzahrani
M Shahzad Rauf
Mahmoud A Elshenawy
Irfan Maghfoor

Frontiers in Oncology

doi 10.3389/fonc.2025.1639819

535 views

Original Research

Published on 09 Sep 2025

Soluble B-cell maturation antigen as a serum marker of MRD in patients with multiple myeloma

in Hematologic Malignancies

Erin A. Dean
Derek M. Li
Tuo Lin
Edith M. Sampson
Robert P. Seifert
Jack W. Hsu
John W. Hiemenz
John R. Wingard

Frontiers in Oncology

doi 10.3389/fonc.2025.1631511

348 views

Case Report

Accepted on 08 Sep 2025

Case report: A rare RUNX1 rearrangement resulting from t(8;21)(p12;q22) in acute myeloid leukemia with plasmacytoid dendritic cell expansion

in Hematologic Malignancies

Jinying Gong
Jialong Liu
Lisha Lu
Jiru Wei
Xue Wu
Junyan Zou
Yuan Feng
Zhu Guoqing
Jing Han

Frontiers in Oncology

doi 10.3389/fonc.2025.1672416

195 views

Case Report

Accepted on 08 Sep 2025

Zanubrutinib as a Salvage Therapy for Ibrutinib-Resistant Chronic Lymphocytic Leukemia: A Case Report

in Hematologic Malignancies

Zhenhui Lv
Ping Lu
Changhua Jing
Xuena Yi
Xueqiong Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1671124

171 views

Mini Review

Accepted on 08 Sep 2025

Immunoparesis in Multiple Myeloma: A Current Overview

in Hematologic Malignancies

Hong Feng Wang
Jianbin Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1628144

Case Report

Accepted on 08 Sep 2025

Venetoclax as a cytoreduction therapy option for acute promyelocytic leukaemia in newly diagnosed adult patients: a case report of a 35-year-old female with schizophrenia

in Hematologic Malignancies

Lingling Wang
Yuqing Miao
Yuexin Cheng

Frontiers in Oncology

doi 10.3389/fonc.2025.1671529

133 views

Original Research

Published on 08 Sep 2025

Bone marrow involvement in solid tumors - a retrospective observational study

in Hematologic Malignancies

Bicheng Zhang
Lan Jin
Dang Wu
Jing Xu
Siyu Guo
Jingjing Li
Ting Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1434709

421 views

Case Report

Published on 08 Sep 2025

Posterior reversible encephalopathy syndrome after CD19 chimeric antigen receptor therapy for B-acute lymphoblastic leukemia: case report

in Hematologic Malignancies

Rohan Dipesh Agarwal
Ranju Kunwor
Kavya Sudanagunta

Frontiers in Oncology

doi 10.3389/fonc.2025.1639892

564 views

Original Research

Accepted on 05 Sep 2025

Targeting RAB7 in human B lymphoma by a small molecule inhibitor arrests tumor cell growth

in Hematologic Malignancies

Maria Fernandez
Rui Wang
Jingwei Wang
Kenneth Holder
Alia Nazarullah
Ricardo Aguiar
Hui Yan
Zhenming Xu

Frontiers in Oncology

doi 10.3389/fonc.2025.1616519

413 views

Case Report

Published on 05 Sep 2025

Successful CD19 chimeric antigen receptor T-cell therapy following autologous stem cell transplantation in a secondary central nervous system lymphoma patient with COVID-19 infection: a case report and literature review

in Hematologic Malignancies

Xiaoning Wang
Juan Ren
Yuqi Wang
Minna Luo
Jing Li
Pengcheng He

Frontiers in Oncology

doi 10.3389/fonc.2025.1656034

601 views